STD Vaccine
Research Study
Research Study
Researchers at UNC Chapel Hill are partnering with healthy volunteers who were assigned male sex at birth to determine whether an FDA-approved vaccine against blood infections could also provide protection against gonorrhea.
Study Consists of Up to 21 Visits Over 6 months
Compensation Up to $1,110
Assigned Male Sex at birth
Generally Healthy
18-35 Years Old
Fast Facts
About Our Research Study
| Gonorrhea is a common STD that can cause infection in the genitals, rectum, and throat. It is spread by having sex (oral, vaginal, or anal) with someone who has the disease. Researchers at UNC Chapel Hill have been working for over two decades to create prevention measures against gonorrhea. The goal of this study is to determine whether an FDA-approved meningitis B vaccine, BexseroTM, can help protect against the bacteria that causes gonorrhea. Join today to help researchers learn more about STD prevention! Compensation provided. |
Additional Information
We want to investigate whether a vaccine that's already approved for preventing bacterial infections of the bloodstream can provide protection against gonorrhea.
You may qualify for this study if you meet the following criteria.
Key Criteria:
Key Criteria:
- Generally healthy
- Assigned male sex at birth
- 18 to 35 years old
- You are able and willing to abstain from sexual activity involving contact with the penis
- You live in or are willing to travel to Chapel Hill, NC
- The study consists of 11 to 21 test visits spanning over the course of 6 months.
- Participants will receive a lab-made strain of gonorrhea through an inoculation procedure. This involves using a very small tube called catheter to place a specially prepared fluid with gonorrhea into the urethra (opening) of the penis. The procedure itself lasts less than one minute.
- All participants will receive two doses of the meningitis B vaccine (BexseroTM), one dose of the standard flu vaccine, and one dose the standard tetanus and diphtheria vaccine. All vaccines have been approved by the FDA.
- Half of the participants will be randomized to receive 2-dose series of BexseroTM prior to the primary study procedure.
- The other half will receive the BexseroTM vaccines after the primary study procedure.
- Following the primary study procedure, participants will come to our research clinic every morning for up to 10 days to provide urine samples and be evaluated for signs of gonorrhea infection.
- If at any point during those 10 days an infection is suspected or you decide you would like to be treated, oral antibiotics will be administered. The antibiotics administered are 100% effective in clearing the gonorrhea germ from the body.
Compensation up to $1,110 is provided for participation in this study.
There is no cost for you to participate in our research study.